A prospective controlled study of interferon‐based therapy of chronic hepatitis C in patients on methadone maintenance

Stefan Mauss, Florian Berger, Joerg Goelz, Bernhard Jacob, Günther Schmutz – 30 June 2004 – We examined the feasibility of hepatitis C treatment in patients on opioid maintenance. One hundred patients with chronic hepatitis C, 50 on methadone maintenance, and 50 with no intravenous drug use or opioid maintenance for at least 5 years were prospectively matched for sex, age, hepatitis C virus (HCV) genotype and HCV RNA. The primary end point was undetectable HCV RNA at 24 weeks posttreatment.

Adiponectin protects LPS‐induced liver injury through modulation of TNF‐α in KK‐Ay obese mice

Takayuki Masaki, Seiichi Chiba, Hiroshi Tatsukawa, Tohru Yasuda, Hitoshi Noguchi, Masataka Seike, Hironobu Yoshimatsu – 30 June 2004 – Adiponectin, an adipocytokine, has been identified in adipose tissue, and its receptors are widely distributed in many tissues, including the liver. The present study was performed to clarify the role of adiponectin in lipopolysaccharide (LPS)‐induced liver injury using KK‐Ay obese mice. We analyzed the effects of adiponectin pretreatment on liver injury induced by D‐galactosamine/LPS (GalN/LPS) in KK‐Ay obese mice.

Cost‐minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis

Jayant A. Talwalkar, Paul Angulo, C. Daniel Johnson, Bret T. Petersen, Keith D. Lindor – 30 June 2004 – Investigations examining the use of magnetic resonance cholangiography (MRC) for the diagnosis of primary sclerosing cholangitis (PSC) have described comparable accuracy when compared to endoscopic retrograde cholangiopancreatography (ERCP). The effectiveness of MRC based on overall cost, however, remains unknown. Our aim was to determine the average cost per correct diagnosis using MRC or ERCP as the initial testing strategy for the diagnosis of PSC.

Sildenafil for portopulmonary hypertension in a patient undergoing liver transplantation

Heikki Makisalo, Anu Koivusalo, Anne Vakkuri, Krister Hockerstedt – 29 June 2004 – Liver transplantation (LT) may be indicated in cirrhotic patients with underlying pulmonary artery hypertension. However, severe pulmonary artery hypertension with mean pulmonary artery pressure (mPAP) above 50 mmHg has even been considered a contraindication to LT. We present a cirrhotic patient with an mPAP of 56 mmHg measured using right heart catheterization (RHC) and with severely compromised physical capacity.

Bacteremias in liver transplant recipients: Shift toward gram‐negative bacteria as predominant pathogens

Nina Singh, Marilyn M. Wagener, Asia Obman, Thomas V. Cacciarelli, Michael E. de Vera, Timothy Gayowski – 29 June 2004 – During the 1990s, gram‐positive bacteria emerged as major pathogens after liver transplantation. We sought to determine whether the pathogens associated with bacteremias in liver transplant recipients have changed. Patients included 233 liver transplant recipients transplanted between 1989 and 2003. The proportion of all infections due to bacteremias increased significantly over time (P < .0001).

Recovery from a variegate porphyria by a liver transplantation

Nathalie Stojeba, Carole Meyer, Catherine Jeanpierre, Frédéric Perrot, Christine Hirth, Thierry Pottecher, Jean‐Charles Deybach – 29 June 2004 – The porphyrias are a group of inherited or acquired enzymatic defects of heme biosynthesis. Each type of porphyria has a characteristic pattern of overproduction and accumulation of heme precursors based on the location of dysfunctional enzyme in the heme synthetic pathway.

Subscribe to